More granular segmentation of the mid-end private medical insurance (PMI) market is expected in China in the short- to medium term, notes Swiss Re Institute (SRI) in a new sigma report.
Please login to read the full news
Note that your comment may be edited or removed in the future, and that your comment may appear alongside the original article on websites other than this one.
more »
Brought to you by